Meanwhile, inhibition of DTX3L expression has been shown to enhance the sensitivity to chemotherapy and increase the expression of caspase-3 and PARP1 in multiple myeloma cell lines, thus promoting apoptosis (Shen et al., 2017). This evidence concerns the gene PARP1 and plasma cell myeloma.